JEN Stock Analysis: Jenoptik | XETRA
Electronic Components | XETRA, Germany | Market Cap: 2.263m EUR | 12M Return: 132.5% | DE000A2NB601 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.03M
EPS Trend: 32.8%
Qual. Beats: 0
Rev. Trend: -40.5%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Jenoptik AG is a German photonics company that operates through four main segments: Semiconductor & Advanced Manufacturing, Biophotonics, Metrology & Production Solutions, and Smart Mobility Solutions. Its product portfolio spans imaging systems and cameras, laser technology, optical and microoptical components, optoelectronic systems, and road safety solutions such as speed and red-light enforcement cameras. The company serves a diverse range of end markets, including automotive, defense and security, data communication, medical technology, semiconductor equipment, and public safety. Founded in 1846 and headquartered in Jena, Germany, Jenoptik is classified within the Semiconductor Materials & Equipment sub-industry, reflecting its significant exposure to photonics-enabled manufacturing tools used in semiconductor production processes.
- Semiconductor equipment orders rebound on EUV lithography demand
- Smart Mobility traffic enforcement contracts expand in Europe and US
- Biophotonics margins pressured by Asian competition and pricing
| Net Income: 87.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.15 > 1.0 |
| NWC/Revenue: 36.24% < 20% (prev 19.21%; Δ 17.03% < -1%) |
| CFO/TA 0.10 > 3% & CFO 178.6m > Net Income 87.3m |
| Net Debt (368.5m) to EBITDA (208.6m): 1.77 < 3 |
| Current Ratio: 2.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (57.2m) vs 12m ago -0.46% < -2% |
| Gross Margin: 34.49% > 18% (prev 32.28%; Δ 2.21% > 0.5%) |
| Asset Turnover: 61.50% > 50% (prev 64.79%; Δ -3.29% > 0%) |
| Interest Coverage Ratio: 7.59 > 6 (EBIT TTM 132.9m / Interest Expense TTM 17.5m) |
| A: 0.22 (Total Current Assets 653.1m - Total Current Liabilities 272.2m) / Total Assets 1.76b |
| B: 0.37 (Retained Earnings 650.2m / Total Assets 1.76b) |
| C: 0.08 (EBIT TTM 132.9m / Avg Total Assets 1.71b) |
| D: 1.40 (Book Value of Equity 1.02b / Total Liabilities 732.8m) |
| Altman-Z'' = 4.61 = AA |
| DSRI: 1.11 (Receivables 221.1m/203.3m, Revenue 1.05b/1.07b) |
| GMI: 0.94 (GM 32.28% / 34.49%) |
| AQI: 0.92 (AQ_t 0.39 / AQ_t-1 0.42) |
| SGI: 0.98 (Revenue 1.05b / 1.07b) |
| TATA: -0.05 (NI 87.3m - CFO 178.6m) / TA 1.76b) |
| Beneish M = -3.06 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at EUR 40.68 with a total of 88,351 shares traded. Over the past week, the price has changed by +2.88%, over one month by +4.85%, over three months by -13.26% and over the past year by +132.48%.
Current recommended Stop Loss: 38.90 (which is 4.4% or 1.2 ATR below the current price).
Jenoptik has no consensus analysts rating.
P/E Trailing = 26.1854
P/E Forward = 16.2602
P/S = 2.1539
P/B = 2.2104
P/EG = 1.1285
Revenue TTM = 1.05b EUR
EBIT TTM = 132.9m EUR
EBITDA TTM = 208.6m EUR
Long Term Debt = 367.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 23.5m EUR (from shortTermDebt, last quarter)
Debt = 494.9m EUR (from shortLongTermDebtTotal, last quarter) + Leases 59.1m
Net Debt = 368.5m EUR (calculated: Debt 494.9m - CCE 126.4m)
Enterprise Value = 2.63b EUR (2.26b + Debt 494.9m - CCE 126.4m)
Interest Coverage Ratio = 7.59 (Ebit TTM 132.9m / Interest Expense TTM 17.5m)
EV/FCF = 20.30x (Enterprise Value 2.63b / FCF TTM 129.6m)
FCF Yield = 4.93% (FCF TTM 129.6m / Enterprise Value 2.63b)
FCF Margin = 12.34% (FCF TTM 129.6m / Revenue TTM 1.05b)
Net Margin = 8.31% (Net Income TTM 87.3m / Revenue TTM 1.05b)
Gross Margin = 34.49% ((Revenue TTM 1.05b - Cost of Revenue TTM 688.3m) / Revenue TTM)
Gross Margin QoQ = 36.76% (prev 35.41%)
Tobins Q-Ratio = 1.49 (Enterprise Value 2.63b / Total Assets 1.76b)
Interest Expense / Debt = 3.54% (Interest Expense 17.5m / Debt 494.9m)
Taxrate = 28.88% (35.8m / 123.9m)
NOPAT = 94.5m (EBIT 132.9m * (1 - 28.88%))
Current Ratio = 2.40 (Total Current Assets 653.1m / Total Current Liabilities 272.2m)
Debt / Equity = 0.48 (Debt 494.9m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = 1.77 (Net Debt 368.5m / EBITDA 208.6m)
Debt / FCF = 2.84 (Net Debt 368.5m / FCF TTM 129.6m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.11% (Net Income 87.3m / Total Assets 1.76b)
RoE = 8.68% (Net Income TTM 87.3m / Total Stockholder Equity 1.01b)
RoCE = 9.67% (EBIT 132.9m / Capital Employed (Equity 1.01b + L.T.Debt 367.0m))
RoIC = 6.48% (NOPAT 94.5m / Invested Capital 1.46b)
WACC = 9.19% (E(2.26b)/V(2.76b) * Re(10.65%) + D(494.9m)/V(2.76b) * Rd(3.54%) * (1-Tc(0.29)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 29.56 | Cagr: 0.46%
[DCF] Terminal Value 75.30% ; FCFF base≈105.7m ; Y1≈121.1m ; Y5≈178.3m
[DCF] Fair Price = 34.39 (EV 2.34b - Net Debt 368.5m = Equity 1.97b / Shares 57.2m; r=9.19% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 32.83 | EPS CAGR: 4.30% | SUE: 0.12 | # QB: 0
Revenue Correlation: -40.53 | Revenue CAGR: -1.14% | SUE: -1.36 | # QB: -1
EPS current Quarter (2026-09-30): EPS=0.59 | Chg30d=-0.66% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=1.92 | Chg30d=+2.81% | Revisions=+40% | GrowthEPS=+59.2% | GrowthRev=+8.4%
EPS next Year (2027-12-31): EPS=2.43 | Chg30d=+5.24% | Revisions=+57% | GrowthEPS=+26.5% | GrowthRev=+10.0%
[Analyst] Revisions Ratio: +67% (up=6, down=0)